Regulatory T cells suppress anti-tumor immune response through attenuating CD8+ T-cell functions, which are dependent on the release of multiple immunosuppressive cytokines and high levels of expression of immune-checkpoint molecules (130). This evidence concerns the gene CD8A and neoplasm.